Navigation Links
Genetic Pattern May Predict Leukemia Relapse

Children could be screened, treated more aggressively if deemed at risk, researchers say

THURSDAY, May 13 (HealthDay News) -- Researchers have linked a genetic pattern to the likelihood that patients with a severe form of childhood leukemia will relapse.

The finding could lead doctors to screen for the pattern and treat those who have it more aggressively from the time of diagnosis, the researchers added.

The kids in question have T-cell acute lymphoblastic leukemia, which accounts for about 15 percent of childhood leukemia cases.

While as many as 80 percent of children with the disease go into remission, about 20 percent relapse, study co-author Alex Beesley, of Perth's Telethon Institute for Child Health Research in Australia, said in a news release.

The prognosis for those patients can be grim, he said.

"In this study, we found a consistent pattern in the expression of five genes in patients that relapse," Beesley said. "Importantly, this pattern was found to hold true across multiple patient cohorts, the first time that such a robust gene signature of this kind has been found" for the type of leukemia in question.

"Patients identified using these markers could potentially be treated with more aggressive therapies from the outset to give them the best hope of achieving complete remission," Beesley said.

The study authors came to their conclusions after analyzing bone-marrow samples from children with leukemia. They found a genetic pattern that successfully predicted what would happen to 50 patients with the form of leukemia.

The findings were published online May 12 in the journal Molecular Cancer.

More information

For more about leukemia in kids, see the U.S. National Library of Medicine.

-- Randy Dotinga

SOURCE: BioMed Central, news release, May 11, 2010

Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Walgreens Postpones Plans to Sell Do-It-Yourself Genetic Test
2. Genetic pattern that predicts leukemia relapse discovered
3. Resveratrol Supplement Company RevGenetics Welcomes New Chief Science Officer
4. Genetic Variants Tied to MS, Study Finds
5. UT Southwestern participates in nationwide study offering free lung tumor genetic testing
6. Genetic Research Sheds Light on Chronic Pain
7. High doses of antioxidant supplements induce stem cell genetic abnormalities
8. New research about human genetic diseases and human development
9. Genetics, Psychology May Trigger ADHD
10. Plant pathogen genetically tailors attacks to each part of host, say Stanford researchers
11. Study finds changes in fetal epigenetics throughout pregnancy
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... Avid collector, Andrew Hawley ... Michigan boxing style concert posters. This is one of Joplin's most famous and beautiful ... at the University of Michigan in Ann Arbor. The According to Hawley, "It is ...
(Date:11/26/2015)... ... November 26, 2015 , ... Patients at ... Michigan, have come together on Thanksgiving Day to share the things that they ... on the Serenity Point YouTube channel, patients displayed what they wrote on index ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... eReferral system for diagnostic imaging in the Waterloo region. Using the Ocean Platform, ... Medicine tests directly from their electronic medical record (EMR) without the need for ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent ... and the need to integrate dose form selection in early phase drug development. ... membership organization supporting and bringing together the UK’s emerging life sciences companies, corporate ...
(Date:11/26/2015)... , ... November 26, 2015 , ... PRMA Plastic Surgery ... 19, 2015, our surgeons performed their 6,000th free flap breast reconstruction surgery! , “What ... up every day excited to rebuild lives and it’s an honor to have served ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... November 26, 2015 ... the "Radioimmunoassay Market by Type (Reagents ... Industry, Academics, Clinical Diagnostic Labs), Application (Research, ... to 2020" report to their offering. ... the addition of the "Radioimmunoassay Market ...
(Date:11/25/2015)... Nov. 25, 2015  Amgen (NASDAQ: AMGN ) ... (BLA) with the United States ... a biosimilar candidate to Humira ® (adalimumab). Amgen ... submitted to the FDA and represents Amgen,s first BLA ... E. Harper , M.D., executive vice president of Research ...
(Date:11/25/2015)... , Nov. 25, 2015 On Tuesday, ... federal bellwether trial against Wright Medical Technology, Inc. ... their Conserve metal-on-metal hip implant device, awarded $11 ... a two week trial and three days of ... hip device was defectively designed and unreasonably dangerous, ...
Breaking Medicine Technology: